Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization. [electronic resource]
Producer: 20210608Description: 52-65.e7 p. digitalISSN:- 2405-4720
- Acrylamides -- administration & dosage
- Adenocarcinoma of Lung -- drug therapy
- Aniline Compounds -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Benzimidazoles -- administration & dosage
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- genetics
- Erlotinib Hydrochloride -- administration & dosage
- Genetic Fitness
- Genotype
- Humans
- Lung Neoplasms -- drug therapy
- MAP Kinase Signaling System
- Mutation
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.